Arena Clinical Trial Supply Europe



Speaker : Sylvain Berthelot

Session: Will direct-to-patient shipment shift from emergency solution to routine practice?

  • Reflect on how it was applied as a response to the pandemic
  • Highlight the risks of DtP and how they can be mitigated
  • Discuss how to approach a direct-to-patient strategy
  • Consider how the process can be improved in the future

When: Tuesday (Day 1) @ 12:30 CET- Clinical Technology Stream


Novotel Madrid Center Hotel
March 22-23, 2022
Booth #5

March 22, 2022


Sylvain Berthelot image

Sylvain Berthelot

Sr. Dir. Voice of Customer & Strategy

Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.